Wound care company sees potential in regenerative medicine

02/9/2011 | Today's Wound Clinic magazine

Advanced BioHealing makes Dermagraft -- a wound care product that contains living human fibroblast cells, an extracellular matrix and an absorbable scaffold -- which is approved to treat diabetic foot ulcers and is in clinical trials for healing venous leg ulcers, Senior Vice President Dean Tozer said. "This approach to healing wounds is a prime example of the potential of the emerging field regenerative medicine," Tozer said in this interview with Today's Wound Clinic. The company also developed a community health education program to raise awareness about diabetic foot ulcers.

View Full Article in:

Today's Wound Clinic magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA